Could a cancer drug tame multiple sclerosis? new trial launches
NCT ID NCT03783416
First seen Sep 30, 2025 · Last updated May 11, 2026 · Updated 25 times
Summary
This study tests whether a drug called ixazomib, currently used for cancer, is safe for people with multiple sclerosis (MS). About 72 adults with relapsing-remitting or progressive MS will take either ixazomib capsules or a placebo for up to 24 months. Researchers will monitor side effects and check if the drug reduces certain immune markers in the spinal fluid linked to MS activity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSING REMITTING MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Royal London Hospital, Barts Health NHS Foundation Trust
RECRUITINGLondon, Greater London, E1 1BB, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.